{"id":345539,"date":"2026-11-12T23:44:02","date_gmt":"2026-11-12T18:14:02","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/"},"modified":"2026-11-12T23:44:02","modified_gmt":"2026-11-12T18:14:02","slug":"gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/","title":{"rendered":"GAUDIUM IVF N WOMEN H L Q2 Results FY27: PAT Jumps 428.65% QoQ, Revenue Rs 37.41 Cr, PAT Rs 9.41 Cr"},"content":{"rendered":"<div style=\"background:#F0F9FF;border-left:4px solid #2E7D32;border-radius:6px;padding:14px 18px;margin:18px 0;\">\n<p style=\"margin:0;color:#1F4E79;font-size:14px;\"><strong>Quick Answer<\/strong><\/p>\n<p style=\"margin:8px 0 0;\"><a href=\"https:\/\/univest.in\/stocks\/gaudiumivf\/gaudium-ivf-n-women-h-l-share-price-today\">GAUDIUM IVF N WOMEN H L<\/a> Q2 Results FY27 were declared on 12 November 2026 on a consolidated basis. Revenue rose 93.03% to Rs 37.41 Cr from Rs 19.38 Cr in the previous quarter, and that QoQ growth came with net profit of Rs 9.41 Cr, up 428.65% from Rs 1.78 Cr. Operating Profit was Rs 13.47 Cr, up 456.61% from Rs 2.42 Cr, so these quarterly results moved higher on every reported line.<\/p>\n<\/div>\n<p>GAUDIUM IVF N WOMEN H L (GAUDIUMIVF) Q2 Results FY27 announced on 12 November 2026, covering the company&#8217;s financial performance for the July to September quarter. Consolidated results show revenue of Rs 37.41 Cr and PAT of Rs 9.41 Cr. With the results date now confirmed, GAUDIUM IVF N WOMEN H L Q2 Results FY27 can be read against the previous quarter, where net profit was Rs 1.78 Cr and revenue was Rs 19.38 Cr.<\/p>\n<p>This results analysis of GAUDIUM IVF N WOMEN H L Q2 Results covers the financial highlights, business drivers, outlook and risks in order. Readers who want to check the figures independently can use the Univest Screener, and the Financial Highlights table that follows gives the exact numbers for this quarter and the previous quarter.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/user\/log-in?utm_source=blogs&#038;utm_medium=quarterly_results\"><strong>Click Here &#8211; Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_Financial_Highlights\" title=\"GAUDIUM IVF N WOMEN H L Q2 Results FY27: Financial Highlights\">GAUDIUM IVF N WOMEN H L Q2 Results FY27: Financial Highlights<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Key_Takeaways_from_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_What_Stands_Out\" title=\"Key Takeaways from GAUDIUM IVF N WOMEN H L Q2 Results: What Stands Out\">Key Takeaways from GAUDIUM IVF N WOMEN H L Q2 Results: What Stands Out<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_Performance_Analysis\" title=\"GAUDIUM IVF N WOMEN H L Q2 Results FY27: Performance Analysis\">GAUDIUM IVF N WOMEN H L Q2 Results FY27: Performance Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Key_Business_Factors_This_Quarter\" title=\"Key Business Factors This Quarter\">Key Business Factors This Quarter<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#FY27_Outlook_After_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\" title=\"FY27 Outlook After GAUDIUM IVF N WOMEN H L Q2 Results\">FY27 Outlook After GAUDIUM IVF N WOMEN H L Q2 Results<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Key_Risks_to_Watch_After_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"Key Risks to Watch After GAUDIUM IVF N WOMEN H L Q2 Results FY27\">Key Risks to Watch After GAUDIUM IVF N WOMEN H L Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Volatile_quarterly_net_profit\" title=\"Volatile quarterly net profit\">Volatile quarterly net profit<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Lower_return_on_equity\" title=\"Lower return on equity\">Lower return on equity<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Lower_return_on_capital_employed\" title=\"Lower return on capital employed\">Lower return on capital employed<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Frequently_Asked_Questions_on_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"Frequently Asked Questions on GAUDIUM IVF N WOMEN H L Q2 Results FY27\">Frequently Asked Questions on GAUDIUM IVF N WOMEN H L Q2 Results FY27<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_are_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What are GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What are GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_is_the_results_date_for_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What is the results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What is the results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_revenue_was_reported_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What revenue was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What revenue was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_net_profit_was_reported_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What net profit was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What net profit was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#How_much_QoQ_growth_did_revenue_show_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"How much QoQ growth did revenue show in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">How much QoQ growth did revenue show in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Did_net_profit_rise_or_fall_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\" title=\"Did net profit rise or fall in GAUDIUM IVF N WOMEN H L Q2 Results?\">Did net profit rise or fall in GAUDIUM IVF N WOMEN H L Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_was_the_Operating_Profit_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What was the Operating Profit in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What was the Operating Profit in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Are_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_consolidated_results_or_standalone_results\" title=\"Are GAUDIUM IVF N WOMEN H L Q2 Results consolidated results or standalone results?\">Are GAUDIUM IVF N WOMEN H L Q2 Results consolidated results or standalone results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-20\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_business_factors_shaped_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What business factors shaped GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What business factors shaped GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-21\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_are_the_key_risks_after_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\" title=\"What are the key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27?\">What are the key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-22\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#What_is_the_outlook_after_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\" title=\"What is the outlook after GAUDIUM IVF N WOMEN H L Q2 Results?\">What is the outlook after GAUDIUM IVF N WOMEN H L Q2 Results?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-23\" href=\"https:\/\/univest.in\/blogs-2\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-9-crore\/#Where_can_I_find_the_complete_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_data\" title=\"Where can I find the complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data?\">Where can I find the complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_Financial_Highlights\"><\/span><strong>GAUDIUM IVF N WOMEN H L Q2 Results FY27: Financial Highlights<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table>\n<tbody>\n<tr>\n<th>Metric<\/th>\n<th>Q2 FY27 (Sep 26)<\/th>\n<th>Q1 FY27 (Jun 26)<\/th>\n<th>QoQ Change<\/th>\n<\/tr>\n<tr>\n<td><strong>Revenue<\/strong><\/td>\n<td>Rs 37.41 Cr<\/td>\n<td>Rs 19.38 Cr<\/td>\n<td>+93.03% QoQ<\/td>\n<\/tr>\n<tr>\n<td><strong>Operating Profit<\/strong><\/td>\n<td>Rs 13.47 Cr<\/td>\n<td>Rs 2.42 Cr<\/td>\n<td>+456.61% QoQ<\/td>\n<\/tr>\n<tr>\n<td><strong>Net Profit (PAT)<\/strong><\/td>\n<td>Rs 9.41 Cr<\/td>\n<td>Rs 1.78 Cr<\/td>\n<td>+428.65% QoQ<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source: company filing for GAUDIUM IVF N WOMEN H L Q2 Results FY27, 12 November 2026. Figures in Rs Crore, Consolidated basis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Takeaways_from_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_What_Stands_Out\"><\/span><strong>Key Takeaways from GAUDIUM IVF N WOMEN H L Q2 Results: What Stands Out<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li><strong>Revenue:<\/strong> Rs 37.41 Cr against Rs 19.38 Cr in the previous quarter, a 93.03% rise that anchors the QoQ growth picture for this quarter.<\/li>\n<li><strong>Net profit:<\/strong> Rs 9.41 Cr versus Rs 1.78 Cr, a 428.65% rise, so net profit grew at a far faster pace than revenue.<\/li>\n<li><strong>Operating Profit:<\/strong> Rs 13.47 Cr compared with Rs 2.42 Cr, a 456.61% increase that is the largest percentage move among the three lines.<\/li>\n<li><strong>Margin:<\/strong> Net profit margin improved to 25.2% from 9.2% in the previous quarter, as GAUDIUM IVF N WOMEN H L Q2 Results FY27 show.<\/li>\n<li><strong>Next step:<\/strong> The performance analysis below sets out how these four figures fit together for the quarter.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_Performance_Analysis\"><\/span><strong>GAUDIUM IVF N WOMEN H L Q2 Results FY27: Performance Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GAUDIUM IVF N WOMEN H L Q2 Results show consolidated revenue of Rs 37.41 Cr for July to September 2026, up 93.03% QoQ from Rs 19.38 Cr, while net profit rose 428.65% to Rs 9.41 Cr. Operating Profit increased 456.61% to Rs 13.47 Cr, so the results analysis shows profit lines growing faster than revenue.<\/p>\n<p>In GAUDIUM IVF N WOMEN H L Q2 Results FY27, the gap between revenue growth and profit growth is the main feature. Revenue added Rs 18.03 Cr QoQ, net profit added Rs 7.63 Cr and Operating Profit added Rs 11.05 Cr. The supplied figures confirm these movements but do not establish a specific cause for them.<\/p>\n<p>Readers following these quarterly results can compare later disclosures against the same QoQ growth and margin markers used here, including the 25.2% net profit margin. The next section lists the disclosed drivers, which is where the results analysis turns to the business factors.<\/p>\n<p style=\"margin-top:24px;\"><a href=\"https:\/\/univest.in\/screeners\"><strong>Check the Univest Screener for live results data<\/strong><\/a><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Business_Factors_This_Quarter\"><\/span><strong>Key Business Factors This Quarter<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p><strong>Revenue growth quarter on quarter<\/strong> &#8211; The results analysis points first to revenue growth of 93.0% QoQ, with revenue at Rs 37.41 Cr in the latest quarter against Rs 19.38 Cr in the previous quarter. This is the disclosed driver of the top-line movement.<\/p>\n<p><strong>Net profit increase<\/strong> &#8211; Net profit rose 428.7% quarter on quarter to Rs 9.41 Cr, which shows that the quarterly results moved higher well ahead of revenue, as recorded in GAUDIUM IVF N WOMEN H L Q2 Results FY27.<\/p>\n<p><strong>Net profit margin<\/strong> &#8211; Net profit margin improved to 25.2% from 9.2% in the comparison quarter, and return on equity was 24.66% in FY26, two ratios that link profit to revenue and to equity.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"FY27_Outlook_After_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\"><\/span><strong>FY27 Outlook After GAUDIUM IVF N WOMEN H L Q2 Results<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The FY27 full-year picture will depend on the remaining quarters and on disclosed sector conditions. GAUDIUM IVF N WOMEN H L Q2 Results FY27 give a consolidated base of Rs 37.41 Cr in revenue and Rs 9.41 Cr in net profit for the second quarter, which later quarters will be measured against.<\/p>\n<p>A results analysis of the coming quarters will show how revenue growth of 93.03% QoQ and net profit relative to the previous quarter&#8217;s Rs 1.78 Cr develop. Operating Profit of Rs 13.47 Cr is another marker, and the Univest Screener lists these figures alongside earlier quarters. These movements also carry risks, which the next section sets out.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Key_Risks_to_Watch_After_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>Key Risks to Watch After GAUDIUM IVF N WOMEN H L Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Volatile_quarterly_net_profit\"><\/span><strong>Volatile quarterly net profit<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Quarterly net profit has been volatile, ranging from Rs 1.78 Cr to Rs 9.41 Cr over the last 5 quarters, which makes the QoQ growth of 428.65% in GAUDIUM IVF N WOMEN H L Q2 Results FY27 a figure that later quarters will test.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lower_return_on_equity\"><\/span><strong>Lower return on equity<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on equity declined to 24.66% in FY26 from 52.34% in FY25, so the profit earned on each rupee of equity was lower in FY26 than in the earlier full year, a ratio investors can check in later disclosures.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Lower_return_on_capital_employed\"><\/span><strong>Lower return on capital employed<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>Return on capital employed declined to 29.95% in FY26 from 50.16% in FY25. This full-year ratio gives context on how much profit the company earns on the capital it uses.<\/p>\n<p style=\"margin-top:24px;\"><em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&#038;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track quarterly results as they are declared.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>GAUDIUM IVF N WOMEN H L Q2 Results FY27 show consolidated revenue up 93.03% QoQ to Rs 37.41 Cr and net profit up 428.65% to Rs 9.41 Cr. These quarterly results also lift Operating Profit to Rs 13.47 Cr. Investors weighing the GAUDIUM IVF N WOMEN H L Q2 Results alongside other consolidated results should consult a SEBI-registered advisor before acting.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice. Research Analyst: Uniresearch Global Pvt. Ltd., SEBI Registration No. INH000013776.<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions_on_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>Frequently Asked Questions on GAUDIUM IVF N WOMEN H L Q2 Results FY27<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_are_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What are GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GAUDIUM IVF N WOMEN H L Q2 Results FY27 are the consolidated quarterly results for July to September 2026, with revenue of Rs 37.41 Cr and net profit of Rs 9.41 Cr, as the Quick Answer box above summarises.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_results_date_for_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What is the results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27 is 12 November 2026, the day the board declared the consolidated figures, so the Financial Highlights table shows this quarter against the previous quarter.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_revenue_was_reported_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What revenue was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GAUDIUM IVF N WOMEN H L reported consolidated revenue of Rs 37.41 Cr, compared with Rs 19.38 Cr in the previous quarter, which means the Performance Analysis section starts from a much higher base.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_net_profit_was_reported_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What net profit was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GAUDIUM IVF N WOMEN H L reported net profit of Rs 9.41 Cr, compared with Rs 1.78 Cr in the previous quarter, and the Key Takeaways section sets this figure beside the revenue change.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_much_QoQ_growth_did_revenue_show_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>How much QoQ growth did revenue show in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue showed QoQ growth of 93.03% in GAUDIUM IVF N WOMEN H L Q2 Results, rising from Rs 19.38 Cr to Rs 37.41 Cr, while the Key Business Factors section lists this rise first among the disclosed drivers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Did_net_profit_rise_or_fall_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\"><\/span><strong>Did net profit rise or fall in GAUDIUM IVF N WOMEN H L Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Net profit rose 428.65% QoQ in GAUDIUM IVF N WOMEN H L Q2 Results, from Rs 1.78 Cr to Rs 9.41 Cr, so the Key Takeaways section places this increase beside the revenue and Operating Profit changes.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_Operating_Profit_in_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What was the Operating Profit in GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Operating Profit was Rs 13.47 Cr in GAUDIUM IVF N WOMEN H L, up 456.61% from Rs 2.42 Cr in the previous quarter, which is a larger percentage change than revenue, as the Performance Analysis explains.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Are_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_consolidated_results_or_standalone_results\"><\/span><strong>Are GAUDIUM IVF N WOMEN H L Q2 Results consolidated results or standalone results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> GAUDIUM IVF N WOMEN H L Q2 Results are consolidated results, which means the revenue of Rs 37.41 Cr and net profit of Rs 9.41 Cr cover the company together with its subsidiaries, as stated in the Conclusion.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_business_factors_shaped_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What business factors shaped GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Revenue growth of 93.0% QoQ, a net profit rise of 428.7% QoQ and a net profit margin of 25.2% shaped GAUDIUM IVF N WOMEN H L, as detailed under Key Business Factors.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_risks_after_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27\"><\/span><strong>What are the key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27 are volatile quarterly net profit, a return on equity that declined to 24.66% in FY26 from 52.34% in FY25, and a lower return on capital employed.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_outlook_after_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results\"><\/span><strong>What is the outlook after GAUDIUM IVF N WOMEN H L Q2 Results?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The FY27 outlook after GAUDIUM IVF N WOMEN H L Q2 Results depends on the remaining quarters and on disclosed sector conditions, so the Outlook section treats Rs 37.41 Cr revenue as the base for later comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_I_find_the_complete_GAUDIUM_IVF_N_WOMEN_H_L_Q2_Results_FY27_data\"><\/span><strong>Where can I find the complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data is in the Financial Highlights table above, while the Univest Screener and the Univest app carry the full financial profile of the company.<\/p>\n<p><script type=\"application\/ld+json\" class=\"faq-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"FAQPage\",\"mainEntity\":[{\"@type\":\"Question\",\"name\":\"What are GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GAUDIUM IVF N WOMEN H L Q2 Results FY27 are the consolidated quarterly results for July to September 2026, with revenue of Rs 37.41 Cr and net profit of Rs 9.41 Cr, as the Quick Answer box above summarises.\"}},{\"@type\":\"Question\",\"name\":\"What is the results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The results date for GAUDIUM IVF N WOMEN H L Q2 Results FY27 is 12 November 2026, the day the board declared the consolidated figures, so the Financial Highlights table shows this quarter against the previous quarter.\"}},{\"@type\":\"Question\",\"name\":\"What revenue was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GAUDIUM IVF N WOMEN H L reported consolidated revenue of Rs 37.41 Cr, compared with Rs 19.38 Cr in the previous quarter, which means the Performance Analysis section starts from a much higher base.\"}},{\"@type\":\"Question\",\"name\":\"What net profit was reported in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GAUDIUM IVF N WOMEN H L reported net profit of Rs 9.41 Cr, compared with Rs 1.78 Cr in the previous quarter, and the Key Takeaways section sets this figure beside the revenue change.\"}},{\"@type\":\"Question\",\"name\":\"How much QoQ growth did revenue show in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue showed QoQ growth of 93.03% in GAUDIUM IVF N WOMEN H L Q2 Results, rising from Rs 19.38 Cr to Rs 37.41 Cr, while the Key Business Factors section lists this rise first among the disclosed drivers.\"}},{\"@type\":\"Question\",\"name\":\"Did net profit rise or fall in GAUDIUM IVF N WOMEN H L Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Net profit rose 428.65% QoQ in GAUDIUM IVF N WOMEN H L Q2 Results, from Rs 1.78 Cr to Rs 9.41 Cr, so the Key Takeaways section places this increase beside the revenue and Operating Profit changes.\"}},{\"@type\":\"Question\",\"name\":\"What was the Operating Profit in GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Operating Profit was Rs 13.47 Cr in GAUDIUM IVF N WOMEN H L, up 456.61% from Rs 2.42 Cr in the previous quarter, which is a larger percentage change than revenue, as the Performance Analysis explains.\"}},{\"@type\":\"Question\",\"name\":\"Are GAUDIUM IVF N WOMEN H L Q2 Results consolidated results or standalone results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"GAUDIUM IVF N WOMEN H L Q2 Results are consolidated results, which means the revenue of Rs 37.41 Cr and net profit of Rs 9.41 Cr cover the company together with its subsidiaries, as stated in the Conclusion.\"}},{\"@type\":\"Question\",\"name\":\"What business factors shaped GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"Revenue growth of 93.0% QoQ, a net profit rise of 428.7% QoQ and a net profit margin of 25.2% shaped GAUDIUM IVF N WOMEN H L, as detailed under Key Business Factors.\"}},{\"@type\":\"Question\",\"name\":\"What are the key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The key risks after GAUDIUM IVF N WOMEN H L Q2 Results FY27 are volatile quarterly net profit, a return on equity that declined to 24.66% in FY26 from 52.34% in FY25, and a lower return on capital employed.\"}},{\"@type\":\"Question\",\"name\":\"What is the outlook after GAUDIUM IVF N WOMEN H L Q2 Results?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The FY27 outlook after GAUDIUM IVF N WOMEN H L Q2 Results depends on the remaining quarters and on disclosed sector conditions, so the Outlook section treats Rs 37.41 Cr revenue as the base for later comparison.\"}},{\"@type\":\"Question\",\"name\":\"Where can I find the complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data?\",\"acceptedAnswer\":{\"@type\":\"Answer\",\"text\":\"The complete GAUDIUM IVF N WOMEN H L Q2 Results FY27 data is in the Financial Highlights table above, while the Univest Screener and the Univest app carry the full financial profile of the company.\"}}]}<\/script><br \/>\n<script type=\"application\/ld+json\" class=\"news-article-schema\">{\"@context\":\"https:\/\/schema.org\",\"@type\":\"NewsArticle\",\"headline\":\"GAUDIUM IVF N WOMEN H L Q2 Results FY27: PAT Jumps 428.65% QoQ, Revenue Rs 37.41 Cr, PAT Rs 9.41 Cr\",\"description\":\"GAUDIUM IVF N WOMEN H L Q2 Results: Consolidated revenue \u20b937.41 Cr, PAT \u20b99.41 Cr. See QoQ growth and results from the 12 November 2026 filing.\",\"author\":{\"@type\":\"Organization\",\"name\":\"Univest\"},\"publisher\":{\"@type\":\"Organization\",\"name\":\"Univest\",\"url\":\"https:\/\/univest.in\"},\"about\":{\"@type\":\"Corporation\",\"name\":\"GAUDIUM IVF N WOMEN H L\"}}<\/script><\/p>\n","protected":false},"excerpt":{"rendered":"<p>GAUDIUM IVF N WOMEN H L Q2 results: revenue up 93.03% QoQ to Rs 37.41 Cr, net profit up 428.65% to Rs 9.41 Cr.<\/p>\n","protected":false},"author":29,"featured_media":345538,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[5331],"tags":[],"class_list":["post-345539","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-https-univest-in-blogs-category-results"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["345538"],"rank_math_title":["GAUDIUM IVF N WOMEN H L Q2 Results FY27: PAT Rs 9.41 Cr, Revenue Rs 37.41 Cr"],"rank_math_description":["GAUDIUM IVF N WOMEN H L Q2 Results: Consolidated revenue \u20b937.41 Cr, PAT \u20b99.41 Cr. See QoQ growth and results from the 12 November 2026 filing."],"rank_math_focus_keyword":["GAUDIUM IVF N WOMEN H L Q2 Results"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/11\/gaudium-ivf-n-women-h-l-q2-results-fy27-pat-jumps-428-65-qoq-revenue-rs-37-41-cr.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/345539","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=345539"}],"version-history":[{"count":0,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/345539\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/345538"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=345539"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=345539"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=345539"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}